Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.400
-0.190 (-11.95%)
Dec 23, 2025, 4:00 PM EST - Market closed
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $123.58 million as of December 24, 2025. Its market cap has increased by 601.70% in one year.
Market Cap
123.58M
Enterprise Value
84.63M
1-Year Change
601.70%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $123.58M, a decrease of -51.81%. That is a compound annual growth rate of -15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 123.58M | 324.14% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 957.96B |
| Johnson & Johnson | 500.65B |
| AbbVie | 401.90B |
| UnitedHealth Group | 293.78B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 258.90B |
| Abbott Laboratories | 218.41B |